Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request
Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request
Academic Journal

Nanoparticles in Clinical Trials: Analysis of Clinical Trials, FDA Approvals and Use for COVID-19 Vaccines.

  • Source: International Journal of Molecular Sciences. Jan2023, Vol. 24 Issue 1, p787. 15p.

Record details

×
Academic Journal

Clinical and Proteomic Associations of SARS-CoV-2 Infection and COVID-19 Vaccination in Multimorbid Patients: A Cross-Sectional Observational Study.

Subjects: COVID-19*/COVID-19*/COVID-19*/prevention & control ; COVID-19*/COVID-19*/COVID-19*/metabolism ; COVID-19*/COVID-19*/COVID-19*/epidemiology

  • Source: International journal of molecular sciences [Int J Mol Sci] 2025 Aug 19; Vol. 26 (16). Date of Electronic Publication: 2025 Aug 19.Publisher: MDPI Country of Publication: Switzerland NLM ID: 101092791 Publication Model: Electronic Cited Medium: Internet ISSN: 1422-0067

Record details

×
Academic Journal

Do Long COVID and COVID Vaccine Side Effects Share Pathophysiological Picture and Biochemical Pathways?

Subjects: COVID-19*/COVID-19*/COVID-19*/immunology ; COVID-19*/COVID-19*/COVID-19*/prevention & control ; COVID-19*/COVID-19*/COVID-19*/physiopathology

  • Source: International journal of molecular sciences [Int J Mol Sci] 2025 Aug 15; Vol. 26 (16). Date of Electronic Publication: 2025 Aug 15.Publisher: MDPI Country of Publication: Switzerland NLM ID: 101092791 Publication Model: Electronic Cited Medium: Internet ISSN: 1422-0067

Record details

×
Academic Journal

The Potential of Extracellular Vesicle-Mediated Spread of Self-Amplifying RNA and a Way to Mitigate It.

  • Source: International Journal of Molecular Sciences. Jun2025, Vol. 26 Issue 11, p5118. 12p.

Record details

×
Academic Journal

Markers of Antiviral Response in SLE Patients After Vaccination Against SARS-CoV-2.

  • Authors : Komorniczak M; Clinic and Department of Nephrology, Transplantology and Internal Diseases, Faculty of Medicine, Medical University of Gdańsk, 80-214 Gdańsk, Poland.; Lisowska KA

Subjects: Lupus Erythematosus, Systemic*/Lupus Erythematosus, Systemic*/Lupus Erythematosus, Systemic*/immunology ; Lupus Erythematosus, Systemic*/Lupus Erythematosus, Systemic*/Lupus Erythematosus, Systemic*/blood ; COVID-19*/COVID-19*/COVID-19*/prevention & control

  • Source: International journal of molecular sciences [Int J Mol Sci] 2025 Oct 21; Vol. 26 (20). Date of Electronic Publication: 2025 Oct 21.Publisher: MDPI Country of Publication: Switzerland NLM ID: 101092791 Publication Model: Electronic Cited Medium: Internet ISSN: 1422-0067

Record details

×
Academic Journal

Peptide Mapping for Sequence Confirmation of Therapeutic Proteins and Recombinant Vaccine Antigens by High-Resolution Mass Spectrometry: Software Limitations, Pitfalls, and Lessons Learned.

  • Authors : Dobrowolski M; Research and Development Department, Mabion S.A., Langiewicza 60, 95-050 Konstantynów Łódzki, Poland.; Department of Medical Biotechnology, Medical University of Lodz, Żeligowskiego 7/9, 90-752 Łódź, Poland.

Subjects: Software* ; Peptide Mapping*/Peptide Mapping*/Peptide Mapping*/methods ; Vaccines, Synthetic*/Vaccines, Synthetic*/Vaccines, Synthetic*/chemistry

  • Source: International journal of molecular sciences [Int J Mol Sci] 2025 Oct 13; Vol. 26 (20). Date of Electronic Publication: 2025 Oct 13.Publisher: MDPI Country of Publication: Switzerland NLM ID: 101092791 Publication Model: Electronic Cited Medium: Internet ISSN: 1422-0067

Record details

×
Academic Journal

Profile of Selected MicroRNAs as Markers of Sex-Specific Anti-S/RBD Response to COVID-19 mRNA Vaccine in Health Care Workers.

  • Authors : Anticoli S; Reference Center for Gender-Specific Medicine, Istituto Superiore di Sanità [Italian National Institute of Health], 00161 Rome, Italy.; Dorrucci M

Subjects: MicroRNAs*/MicroRNAs*/MicroRNAs*/genetics ; MicroRNAs*/MicroRNAs*/MicroRNAs*/blood ; COVID-19*/COVID-19*/COVID-19*/prevention & control

  • Source: International journal of molecular sciences [Int J Mol Sci] 2025 Aug 07; Vol. 26 (15). Date of Electronic Publication: 2025 Aug 07.Publisher: MDPI Country of Publication: Switzerland NLM ID: 101092791 Publication Model: Electronic Cited Medium: Internet ISSN: 1422-0067

Record details

×
Academic Journal

Usefulness of Vaccine Adverse Event Reporting System for Machine-Learning Based Vaccine Research: A Case Study for COVID-19 Vaccines.

  • Authors : Flora J; Department of Computer Science and Engineering, California State University San Bernardino, 5500 University Parkway, San Bernardino, CA 92407, USA.; Khan W

Subjects: COVID-19*/COVID-19*/COVID-19*/epidemiology ; COVID-19*/COVID-19*/COVID-19*/prevention & control ; COVID-19 Vaccines*/COVID-19 Vaccines*/COVID-19 Vaccines*/adverse effects

  • Source: International journal of molecular sciences [Int J Mol Sci] 2022 Jul 26; Vol. 23 (15). Date of Electronic Publication: 2022 Jul 26.Publisher: MDPI Country of Publication: Switzerland NLM ID: 101092791 Publication Model: Electronic Cited Medium: Internet ISSN: 1422-0067

Record details

×
Academic Journal

Moloney Murine Leukemia Virus-like Nanoparticles Pseudo-Typed with SARS-CoV-2 RBD for Vaccination Against COVID-19.

  • Authors : Kratzer B; Institute of Immunology, Center for Pathophysiology, Infectiology and Immunology, Medical University of Vienna, 1090 Vienna, Austria.; Gattinger P

Subjects: COVID-19*/COVID-19*/COVID-19*/prevention & control ; COVID-19*/COVID-19*/COVID-19*/immunology ; COVID-19*/COVID-19*/COVID-19*/virology

  • Source: International journal of molecular sciences [Int J Mol Sci] 2025 Jul 04; Vol. 26 (13). Date of Electronic Publication: 2025 Jul 04.Publisher: MDPI Country of Publication: Switzerland NLM ID: 101092791 Publication Model: Electronic Cited Medium: Internet ISSN: 1422-0067

Record details

×
  • 1-10 of  561 results for ""COVID-19 Vaccines""